Bio-Techne Corp (TECH)公布2024财年第四季度业绩，每股收益达0.42美元，超过分析师预期的0.39美元。公司营收达2.97亿美元，高于预期的2.8614亿美元。消息公布后，Bio-Techne股价盘前上涨3.39%至75.01美元，但随后回落至66.77美元，较前一交易日收盘价下跌0.99%。

Chicago, for ‘The Bear,’ is depicted — accurately — as a place where the goal is not necessarily to win status or acclaim so ...

Choreo LLC increased its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 14.3% in the fourth quarter, Holdings Channel reports. The firm owned 4,812 shares of the biotechnology company’s stock ...

2025年2月4日， Bio-Techne（TECH）披露2笔公司内部人交易情况。高管McManus Matthew于2025年2月1日卖出1642股。 Bio-Techne ...

Herr博士的任命标志着Bio-Techne董事会为期两年寻找退休成员继任者的工作圆满完成。Bio-Techne总裁兼首席执行官Kim Kelderman对Herr博士在生物学和工程学方面的深厚经验与公司战略方向的契合表示热切期待。董事会主席Bob Baumgartner也强调，随着公司蛋白质组学分析仪器业务的扩张，Herr博士在生物工程领域的丰富科学经验将为董事会带来宝贵价值。

Shares of Bio-Techne Corp. shed 3.98% to $69.92 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.67% to 6,066.44 and the Dow ...

MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended ...

Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...

KeyBanc raised the firm’s price target on Bio-Techne (TECH) to $90 from $80 and keeps an Overweight rating on the shares. Overall, fiscal Q2 ...